These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18425361)
1. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies. Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361 [TBL] [Abstract][Full Text] [Related]
2. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma. Xu F; Zhong W; Li J; Shanshen Z; Cui J; Nesland JM; Suo Z Anticancer Res; 2005; 25(4):2943-50. PubMed ID: 16080548 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167 [TBL] [Abstract][Full Text] [Related]
5. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of RAD17 in head and neck cancer. Zhao M; Begum S; Ha PK; Westra W; Califano J Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792 [TBL] [Abstract][Full Text] [Related]
7. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma. Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pim-1 in head and neck squamous cell carcinomas. Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma]. Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519 [TBL] [Abstract][Full Text] [Related]
11. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732 [TBL] [Abstract][Full Text] [Related]
12. ras mutations and expression in head and neck squamous cell carcinomas. Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162 [TBL] [Abstract][Full Text] [Related]
13. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747 [TBL] [Abstract][Full Text] [Related]
15. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. Han L; Dong Z; Qiao Y; Kristensen GB; Holm R; Nesland JM; Suo Z Gynecol Oncol; 2005 Nov; 99(2):278-86. PubMed ID: 16061279 [TBL] [Abstract][Full Text] [Related]
16. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract. Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156 [TBL] [Abstract][Full Text] [Related]
17. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck. Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737 [TBL] [Abstract][Full Text] [Related]
18. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [TBL] [Abstract][Full Text] [Related]
19. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250 [TBL] [Abstract][Full Text] [Related]
20. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma. Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]